The ATS 2025 International Conference offers a robust scientific program highlighting cutting-edge advancements in pulmonary, critical care, and sleep medicine. This includes several Postgraduate Courses, Scientific Symposia, and Meet the Expert Sessions addressing new developments and considerations in health equity and health disparities, as listed below. A curated list of clinical and scientific sessions related to these topics is also available on the ATS365 platform. For more information on these and other sessions to be presented May 16–21 in San Francisco, visit the online Advance Program.
- A104 REVOLUTIONIZING PULMONARY AND CRITICAL CARE: THE IMPACT OF NURSE-LED RESEARCH
- A108 ALL THAT’S WICKED IN ASTHMA
- A11 CENTENNIAL CELEBRATION OF VA’S RESEARCH AND DEVELOPMENT PROGRAM
- A12 IMPLEMENTING PREVENTATIVE AND BEHAVIORAL HEALTH INTERVENTIONS IN PULMONARY MEDICINE
- A13 POTENTIATING THE BENEFITS OF WORKFORCE DIVERSITY
- A16 BEYOND THE DUST: ADVANCING EXPOSURE ASSESSMENT, METABOLOMICS, AND TREATMENT IN OCCUPATIONAL LUNG DISEASES
- A18 BEST TRIALS IN PULMONARY REHABILITATION
- A26 NAVIGATING THE ABCDS OF LONG-TERM OUTCOMES AFTER ICU
- A29 LUNG DISEASE SUSCEPTIBILITY: BRIDGING GENETICS, EXPOSURES, AND ADVANCEMENTS IN DIAGNOSIS
- A4 SPEAKING BUT NOT HEARD: DISPARITIES IN GERIATRIC CRITICAL CARE
- A58 ADDRESSING THE CHALLENGES OF AIR POLLUTION FOR BETTER LUNG HEALTH OUTCOMES
- A6 EVOLVING LANDSCAPE OF RESPIRATORY OUTCOMES IN SURVIVORS OF PREMATURE BIRTH
- A68 EXPANDING HORIZONS IN PULMONARY REHABILITATION: NOVEL APPLICATIONS, OUTCOMES, AND INNOVATIONS
- A75 RUNNING DIAGNOSTICS: WHAT’S NEW IN LUNG PHYSIOLOGY?
- A89 REVOLUTIONIZING RESPIRATORY DISEASE MANAGEMENT WITH MACHINE LEARNING AND AI INSIGHTS
- A90 LEVERAGING ONE HEALTH TO PREPARE FOR EMERGING PATHOGENS AND PANDEMICS
- A91 HOW TO ACHIEVE GLOBAL EQUITY IN MEDICATION ACCESS FOR CHRONIC RESPIRATORY DISEASES: CHALLENGES AND OPPORTUNITIES
- A92 WEIGHING THE BALANCE: EXPANDING LUNG CANCER SCREENING OPPORTUNITIES FOR HIGH-RISK INDIVIDUALS
- A94 DISPARITIES IN COPD, RESPIRATORY INFECTIONS, LUNG CANCER SCREENING AND OTHER AREAS
- B10 BLOOD BASED BIOMARKERS FOR LUNG CANCER SCREENING: FIVE QUESTIONS (AND ANSWERS) TO MOVE THE FIELD FORWARD
- B101 FIXING BARRIERS: UNLOCKING TREATMENT MODALITIES IN INFLAMMATORY LUNG DISEASES
- B107 WHAT’S NEW IN PULMONARY REHABILITATION ASSESSMENT STRATEGIES?
- B110 THE ROAD TO EARLY DETECTION: ADVANCING LUNG CANCER SCREENING THROUGH AI, RISK MODELS, AND REAL-WORLD DATA
- B14 FROM INFLAMMATION TO INFECTION: EXPLORING BREAKTHROUGHS IN AIRWAYS DISEASE
- B17 THE POWER OF TEAM SCIENCE: INTERDISCIPLINARY APPROACHES TO PULMONARY AND CRITICAL CARE
- B18 BEST IN PEDIATRICS
- B31 DISPARITIES IN SLEEP: DIFFERENCES IN OSA DX, CPAP USE, DAYTIME FUNCTION, AND SOCIAL DETERMINANTS OF HEALTH
- B58 EPIDEMIOLOGICAL INSIGHTS INTO LUNG HEALTH AND DISEASE RISK
- B60 ADVANCING PATIENT CARE: THE INTERCONNECTION OF TRAINING, PERSPECTIVES, AND CLINICAL RESULTS IN RESPIRATORY HEALTH
- B7 CLEAR SKIES OR HAZY HORIZONS: DEBATING PERSONAL POLLUTION CONTROL
- B88 NOVEL MANAGEMENT STRATEGIES IN BRONCHIECTASIS
- B9 CONTEMPORARY DISEASE-MODIFYING THERAPIES: UPDATES FOR THE PEDIATRIC PULMONOLOGIST
- B91 BREATH OF COLLABORATION: ACCELERATING DIVERSE PATIENT ACCRUAL IN RESPIRATORY TRIALS
- B94 UNRAVELING THE CODE OF ENVIRONMENTAL EXPOSURE: RESPONSE WITH EPIGENETICS AND OMICS
- B95 OMICS CONTINUE TO IDENTIFY MECHANISMS UNDERLYING CHILDHOOD LUNG DISEASES
- C10 ENHANCING RECRUITMENT AND RETENTION OF MINORITY AND UNDERREPRESENTED POPULATIONS
- C103 IMPROVING PRAXIS, PROCESS AND PEOPLE IN THE ICUs
- C104 ENVIRONMENTAL AND SOCIAL DETERMINANTS OF LUNG HEALTH AND DISEASE
- C11 MICROPLASTICS AND THEIR IMPACT ON HEALTH
- C13 CHALLENGES IN TOBACCO CONTROL: NICOTINE CONCENTRATIONS, SYNTHETIC NICOTINE, AND FLAVORINGS
- C16 ASTHMA TREATMENT, HEALTH SERVICES RESEARCH, AND DISPARITIES
- C17 DELIRIUM, DISPARITIES, AND DISABILITY: ADVANCING EQUITY IN CRITICAL ILLNESS OUTCOMES
- C21 SCREENING THE UNSEEN: ADVANCING LUNG CANCER DETECTION AND ACCESS ACROSS DIVERSE POPULATIONS
- C25 TOWARDS IMPROVING THE DIALOGUE, DECISIONS, AND DIGNITY IN THE ICU
- C55 EXPOSED: INJURY AND CANCER FROM VAPING, MARIJUANA, SMOKE, AND WORKPLACE HAZARDS
- C7 NEXT STEPS: ENHANCING RESEARCH TRIALS IN PULMONARY REHABILITATION TO IMPROVE REAL WORLD IMPLEMENTATION
- C73 ENVIRONMENTAL STRESSORS AND MOLECULAR MECHANISMS DRIVING LUNG INJURY AND DISEASE PATHOGENESIS
- C74 CELLULAR DYNAMICS, ECM REGULATION, AND INNOVATIVE MODELS IN LUNG PATHOBIOLOGY
- C75 COPD: STRUCTURE AND FUNCTION
- C84 PULMONARY-CRITICAL CARE ADVOCACY: CLOSING THE RESEARCH-POLICY GAP
- C89 FROM AIR TO AILMENTS: UNDERSTANDING THE IMPACT OF AIRBORNE POLLUTANTS AND PARTICULATE MATTER FROM DIFFERENT SOURCES ON HEALTH
- C91 AN ADVOCACY FRAMEWORK FOR TOBACCO: EVIDENCE, POLICY, AND REGULATION ACROSS THE LIFESPAN
- D109 THE NEW NORMAL? EARLY SIGNS OF CHRONIC LUNG DISEASE
- D15 VOICES IN THE ICU: NAVIGATING COMMUNICATION, CONSENT, AND CARE AT LIFE’S EDGE
- D16 INDOOR/OUTDOOR AIR POLLUTION: UNCOVERING DISPARITIES AND ADVANCING LUNG HEALTH
- D22 PUBLIC HEALTH RELEVANT RESEARCH IN COVID, INFECTIOUS DISEASE, LUNG CANCER SCREENING, AND OTHER AREAS
- D30 GOING WITH THE FLOW: ABNORMALITIES IN RESPIRATORY MECHANICS
- D4 AI-DRIVEN INNOVATIONS IN PULMONARY AND CRITICAL CARE MEDICINE: A LOOK AHEAD
- D5 RACE & GENETIC ANCESTRY: RELATIONSHIPS BETWEEN A SOCIAL CONSTRUCT AND BIOLOGY
- D7 TECHNOLOGICAL ADVANCEMENTS IN PEDIATRIC PULMONOLOGY: REMOTE DATA AND DECISION SUPPORT
- D8 25 YEARS OF SEVERE ASTHMA RESEARCH PROGRAM: DISCOVERIES AND BEYOND
- D84 STRATEGIES TO IMPROVE PATIENT-CENTEREDNESS AND DIVERSITY IN CLINICAL TRIALS OF OSA CARE
- D86 COMMUNITY ENGAGEMENT FOR PULMONARY AND ENVIRONMENTAL HEALTH RESEARCH: LESSONS LEARNED FROM COMMUNITY PARTNERS, SITE ACCESS, AND RECRUITMENT
- IPC3 Smoking and Vaping: Role of Respiratory Societies in Global Prevention
- IPC4 Quality Management of Chronic Respiratory Diseases in Resource-Constrained Countries
- IPC6 The Power of Communities in Finding and Treating TB
- IPC8 Global Health Leadership: What, Who, Why?
- IPC9 Cross-Continental Challenges: Burnout in Pulmonology Training
- MD11 COPDGENE: A 15-YEAR LONGITUDINAL STUDY UNRAVELING COPD PROGRESSION AND HEALTH OUTCOMES
- MD14 USING NASA SATELLITE DATA TO GUIDE NOVEL AIR QUALITY APPLICATIONS
- MD18 IMPROVING COPD CARE QUALITY USING IMPLEMENTATION SCIENCE METHODS
- MD21 50 YEARS OF SUPPORTING LUNG RESEARCH: THE PARKER B. FRANCIS FELLOWSHIP
- MD25 INSIGHTS FROM THE SUBPOPULATIONS AND INTERMEDIATE OUTCOMES IN COPD STUDY (SPIROMICS ) FAMILY OF STUDIES: EARLY DATA AND FUTURE PLANS
- MD27 UNDERSTANDING DISPARITIES IN CHILDHOOD ASTHMA USING NIH ENVIRONMENTAL INFLUENCES ON CHILD HEALTH OUTCOMES (ECHO) PROGRAM DATA: MULTICENTER APPROACHES
- MD28 HOW DO SHORT-LIVED LUNG INFECTIONS LEAD TO LONG-LASTING LUNG DAMAGE AND CHRONIC DISEASES?
- MD35 UPDATES ON ARDS, PNEUMONIA, AND SPESIS PHENOTYPING CONSORTIUM
- MD6 NIOSH OCCUPATIONAL RESPIRATORY DISEASE UPDATES
- MD8 THE DEVELOPMENT AND EVALUATION OF AN ASTHMA TRIGGERS TRAINING COURSE
- ME101 BEING THE CHANGE: AN ALLYSHIP TOOL KIT FOR CLINICIANS, EDUCATORS AND RESEARCHERS
- ME102 DUAL DUTIES: HEALTHCARE PROVIDERS AS CAREGIVERS
- MTE29 ARTIFICIAL INTELLIGENCE AND THE FUTURE OF PULMONARY MEDICINE
- MTE32 ADVANCED USE OF ASTHMA BIOLOGICS: A CASE-BASED MASTER CLASS
- MTE35 HOW TO IMPLEMENT A COMPREHENSIVE LUNG NODULE PROGRAM
- NCE25 Race-Neutral Spirometry Equations for Children: Implications, Challenges, and Opportunities
- PG10 PULMONARY FUNCTION TESTING: STATE OF THE ART IN 2025
- PG12 STATE OF THE ART: LUNG CANCER IN 2025
- PG14 UPDATES ON LUNG TRANSPLANTATION: WHAT PULMONOLOGISTS NEED TO KNOW
- PG17 OCCUPATIONAL AND ENVIRONMENTAL LUNG DISEASE 101: DOES MY PATIENT HAVE OCCUPATIONAL LUNG DISEASE?
- PG18 EMPOWERING & DEVELOPING THE NEXT GENERATION OF WOMEN & URIM LEADERS
- PG4 METHODOLOGY FOR INNOVATIVE HEALTH EQUITY RESEARCH: A GRANT PROPOSAL WORKSHOP
- PG5 PULMONARY HYPERTENSION: WHAT YOU NEED TO KNOW TODAY
- PG8 INNOVATIVE PRECLINICAL MODELS FOR HUMAN LUNG RESEARCH: BRIDGING THE GAP FROM BENCH TO BEDSIDE
Extend Your ATS 2026 Experience with ATS NOW
ATS NOW offers conference highlights, peer-reviewed sessions, and access to leading experts in pulmonary, critical care, and sleep medicine. ATS 2026 attendees receive complimentary access to the platform through the rest of the calendar year!